Form 8-K - Current report:
SEC Accession No. 0001567619-15-001036
Filing Date
2015-08-04
Accepted
2015-08-04 17:15:52
Documents
10
Period of Report
2015-07-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K s000995x1_8k.htm 8-K 50289
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION s000995x1_ex3-1.htm EX-3.1 107969
3 AMENDED AND RESTATED BY-LAWS s000995x1_ex3-2.htm EX-3.2 138448
4 REORGANIZATION AGREEMENT s000995x1_ex10-1.htm EX-10.1 719400
5 AMENDED AND RESTATED LLC AGREEMENT OF VTV THERAPEUTICS LLC s000995x1_ex10-2.htm EX-10.2 280314
6 INVESTOR RIGHTS AGREEMENT s000995x1_ex10-3.htm EX-10.3 229099
7 EXCHANGE AGREEMENT s000995x1_ex10-4.htm EX-10.4 115283
8 TAX RECEIVABLE AGREEMENT s000995x1_ex10-5.htm EX-10.5 172630
9 2015 OMNIBUS EQUITY INCENTIVE PLAN s000995x1_ex10-6.htm EX-10.6 161137
10 FORM OF NONQUALIFIED OPTION AWARD AGREEMENT s000995x1_ex10-7.htm EX-10.7 51323
  Complete submission text file 0001567619-15-001036.txt   2027376
Mailing Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265
Business Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

EIN.: 473916571 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37524 | Film No.: 151026509
SIC: 2834 Pharmaceutical Preparations